AAGH / America Great Health - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

America Great Health
US ˙ OTCPK

Mga Batayang Estadistika
CIK 1098009
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to America Great Health
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
May 15, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTIO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 America Great Health (Exact name

April 14, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SEC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 America Great Health (Exact na

March 27, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 America Great Health (Exact n

February 25, 2025 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2024 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27873 America Great Health (Exact name of regi

November 15, 2024 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For the Period Ended: September 30, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Period Ended: Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

October 25, 2024 8-K

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 22, 2024 America Great Health (Exact name of registrant as specified in charter) Wyoming (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File N

October 18, 2024 8-K

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 15, 2024 America Great Health (Exact name of registrant as specified in charter) Wyoming (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Num

October 9, 2024 8-K

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):October 08, 2024 America Great Health (Exact name of registrant as specified in charter) Wyoming (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Numb

October 4, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 04, 2024 America Great He

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 04, 2024 America Great Health (Exact name of registrant as specified in charter) Wyoming (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Num

October 2, 2024 8-K

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2024 America Great Health (Exact name of registrant as specified in charter) Wyoming (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File N

September 30, 2024 NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form N-CEN ☐ Form N-CSR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form N-CEN ☐ Form N-CSR For the Period Ended: June 30, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Period Ended: Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

September 26, 2024 8-K

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 25, 2024 America Great Health (Exact name of registrant as specified in charter) Wyoming (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File N

September 17, 2024 8-K

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 16, 2024 America Great Health (Exact name of registrant as specified in charter) Wyoming (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File N

September 10, 2024 8-K

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 09, 2024 America Great Health (Exact name of registrant as specified in charter) Wyoming (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File N

September 3, 2024 8-K

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 30, 2024 America Great Health (Exact name of registrant as specified in charter) 0-27873 Wyoming 98-0178621 (Commission File Number) (State or other jurisdiction of incorporati

June 3, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 America Great Health (Exact name

May 15, 2024 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For the Period Ended: March 31, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Period Ended: Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

February 23, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 America Great Health (Exact na

February 12, 2024 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☐Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☐Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For the Period Ended: December 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Period Ended: Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

February 8, 2024 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 America G

February 8, 2024 EX-10.1

Lease Agreement

EXHIBIT 10.1 AIRCRE STANDARD MULTI-TENANT OFFICE LEASE - GROSS 1. Basic Provisions (“Basic Provisions”). 1.1 Parties. This Lease (“Lease”), dated for reference purposes only October 28, 2020, is made by and between GKT , Alhambra, LP, a Texas Limited Partnership By Star Tours, Inc a Texas Corporation. It's General Partner By David Men President (“Lessor”) and America Great Health “Lessee” (collect

February 8, 2024 CORRESP

1

TEL: 1-626-576-2218 FAX. 1-626-576-1582 WWW.AAGHUS.COM ADD: 1609 W Valley Blvd., STE 338, Alhambra CA 91803 February 5, 2024 Lynn Dicker Division of Corporation Finance Office of Life Science United States Securities and Exchange Commission Re: America Great Health Form 10-K for Fiscal Year Ended June 30, 2023 File No. 000-27873 Dear Ms. Dicker: This letter is being filed by America Great Health (

February 8, 2024 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 2)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 2) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27873 America Great Health

November 17, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 America Great Health (Exact n

November 16, 2023 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No.1)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No.1) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27873 America Great Health

November 1, 2023 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☐Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☐Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For the Period Ended: September 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Period Ended: Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

October 31, 2023 8-K

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 24, 2023 America Great Health (Exact name of registrant as specified in charter) Wyoming (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Num

October 31, 2023 EX-16.1

Letter from Gries & Associates, LLC

EXHIBIT 16.1 Gries & Associates, LLC Certified Public Accountants 501 S. Cherry Street Ste 1100 Denver, Colorado 80246 October 24, 2023 Securities and Exchange Commission Washington, D.C. 20549 Ladies and Gentlemen: We were previously contracted as the auditors of America Great Health (the Company) and issued financial statements for the years ended June 30, 2023 and 2022, and the subsequent revie

October 13, 2023 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27873 America Great Health (Exact name of regi

October 13, 2023 EX-10.1

Lease Agreement

EXHIBIT 10.1 AIRCRE STANDARD MULTI-TENANT OFFICE LEASE - GROSS 1. Basic Provisions (“Basic Provisions”). 1.1 Parties. This Lease (“Lease”), dated for reference purposes only October 28, 2020, is made by and between GKT , Alhambra, LP, a Texas Limited Partnership By Star Tours, Inc a Texas Corporation. It's General Partner By David Men President (“Lessor”) and America Great Health “Lessee” (collect

October 10, 2023 8-K

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 06, 2023 America Great Health (Exact name of registrant as specified in charter) Wyoming (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Num

September 25, 2023 NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form N-CEN ☐ Form N-CSR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form N-CEN ☐ Form N-CSR For the Period Ended: June 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Period Ended: Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

August 7, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 25, 2023 America Great Healt

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 25, 2023 America Great Health (Exact name of registrant as specified in charter) Wyoming (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Number

May 22, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 America Great Health (Exact name

May 15, 2023 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-CEN ☐ Form N-CSR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-CEN ☐ Form N-CSR For the Period Ended: March 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Period Ended: Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

May 9, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2023 (April 28, 2023) AMER

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2023 (April 28, 2023) AMERICA GREAT HEALTH (Exact name of registrant as specified in its charter) Wyoming 000-27873 98-0178621 (State or other jurisdiction of incorporation) Co

May 9, 2023 EX-16

Letter from WWC, P.C. to the Securities and Exchange Commission dated May 3, 2023.

Exhibit 16 May 2, 2023 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-7561 Ladies and Gentlemen: We have read Item 4.01 of America Great Health’s Form 8-K dated May 2, 2023. We agree with the statements made concerning our firm contained therein. Yours truly, /s/ WWC, P.C. San Mateo, California

February 21, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 America Great Health (Exact na

February 14, 2023 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-CEN ☐ Form N-CSR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-CEN ☐ Form N-CSR For the Period Ended: December 31, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Period Ended: Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

February 8, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 America Great Health (Exact n

January 10, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 30, 2022 America Great H

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 30, 2022 America Great Health (Exact name of registrant as specified in charter) Wyoming (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Nu

November 14, 2022 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-CEN ☐ Form N-CSR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form N-CEN ? Form N-CSR For the Period Ended: September 30, 2022 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q For the Transition Period Ended: Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

October 31, 2022 EX-10.1

Lease Agreement

EX-10.1 2 ex431337.htm EXHIBIT 10.1 EXHIBIT 10.1 AIRCRE STANDARD MULTI-TENANT OFFICE LEASE - GROSS 1. Basic Provisions (“Basic Provisions”). 1.1 Parties. This Lease (“Lease”), dated for reference purposes only October 28, 2020, is made by and between GKT , Alhambra, LP, a Texas Limited Partnership By Star Tours, Inc a Texas Corporation. It's General Partner By David Men President (“Lessor”) and Am

October 31, 2022 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2022 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27873 America Great Health (Exact name of regi

September 28, 2022 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 26, 2022 America Great Health (Exact name of registrant as specified in charter) Wyoming (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File N

September 26, 2022 NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form N-CEN ☐ Form N-CSR

NT 10-K 1 amgreat20220926nt10k.htm FORM NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form N-CEN ☐ Form N-CSR For the Period Ended: June 30, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q

September 7, 2022 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 03, 2022 America Great Health (Exact name of registrant as specified in charter) Wyoming (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File N

August 24, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 22, 2022 America Great Health (Exact name of registrant as specified in charter) Wyoming (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Numb

August 23, 2022 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 21, 2022 America Great Health (Exact name of registrant as specified in charter) Wyoming (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Numb

August 16, 2022 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 13, 2022 America Great Health (Exact name of registrant as specified in charter) Wyoming (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Numb

August 3, 2022 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 01, 2022 America Great Health (Exact name of registrant as specified in charter) Wyoming (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Numb

July 22, 2022 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 22, 2022 America Great Health (Exact name of registrant as specified in charter) Wyoming (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Number

May 25, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 America Great Health (Exact name

May 16, 2022 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-CEN ☐ Form N-CSR

NT 10-Q 1 amgreat20220513nt10q.htm FORM NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-CEN ☐ Form N-CSR For the Period Ended: March 31, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q

March 30, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 30, 2022 AMERICA GREAT HEALTH (Exact name of registrant as specified in its charter) Wyoming 000-27873 98-0178621 (State or other jurisdiction of incorporation) Commission File

March 30, 2022 EX-10.1

Employment Agreement of Quinn Chen.

Exhibit 10.1 ???? ??? America Great Health (CA)?????????? ????????? ???1-888-988-1333 ???1609 W Valley Blvd STE 338, Alhambra CA 91803, USA. ??????CEO??Mike Q. Wang ????Queena Wang Party A? America Great Health (CA)?????????? referred to below as ?the Company?? Telephone?1-888-988-1333 Address?1609 W Valley Blvd STE 338, Alhambra CA 91803, USA. CEO?Mike Q. Wang Contact Person?Queena Wang ??? Quinn

March 10, 2022 8-K

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 9, 2022 (March 2, 2022) AMERICA GREAT HEALTH (Exact name of registrant as specified in its charter) Wyoming 000-27873 98-0178621 (State or other jurisdiction of incorporation) C

March 10, 2022 EX-16

Letter from TAAD, LLP to the Securities and Exchange Commission dated March 8, 2022.

Exhibit 16 March 8, 2022 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-7561 Ladies and Gentlemen: We have read Item 4.01 of America Great Health?s Form 8-K dated March 8, 2022. We agree with the statements made concerning our firm contained therein. Yours truly, /s/ TAAD, LLP. Diamond Bar, California

February 14, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 000-27873 America Great Health (Exact

January 25, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 America Great Health (Exact n

January 21, 2022 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2021 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27873 America Great Health (Exact name of regi

January 21, 2022 EX-10.1

Lease Agreement

EX-10.1 2 ex326493.htm EXHIBIT 10.1 EXHIBIT 10.1 AIRCRE STANDARD MULTI-TENANT OFFICE LEASE - GROSS 1. Basic Provisions (“Basic Provisions”). 1.1 Parties. This Lease (“Lease”), dated for reference purposes only October 28, 2020, is made by and between GKT , Alhambra, LP, a Texas Limited Partnership By Star Tours, Inc a Texas Corporation. It's General Partner By David Men President (“Lessor”) and Am

January 13, 2022 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) ? QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 America Great

January 7, 2022 EX-10.1

Lin Supplementary Agreement dated December 31, 2021.

Exhibit 10.1 Employment Agreement Party A: America Great Health (CA) (Hereinafter referred to as ?the Company?) Tel.: 1-626-576-2218 Address: 1609 W Valley Blvd STE 338, Alhambra CA 91803, USA. Legal Representative: Mike Wang Contact person: Queena Wang Party B: Zhigong Lin Tel.: 1-832-983-0398, E-mail: [email protected] Address: 5706 Brook Bend Dr, Sugar Land TX 77479 Party A is a listed company (s

January 7, 2022 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 7, 2022 (December 31, 2021) AMERICA GREAT HEALTH (Exact name of registrant as specified in its charter) Wyoming 000-27873 98-0178621 (State or other jurisdiction of incorporat

December 29, 2021 EX-10.1

Advisory Committee Member Consulting Agreement with Iden Michael Borkin dated December 10, 2021.

Exhibit 10.1 ADVISORY COMMITTEE MEMBER CONSULTING AGREEMENT THIS ADVISORY COMMITTEE MEMBER CONSULTING AGREEMENT (?Agreement?) is made as of December 10, 2021, by and between AMERICA GREAT HEALTH, a California corporation (the ?Company?), and IDEN MICHAEL BORKIN (?Consultant?). R E C I T A L S : A. Company has formed an Advisory Committee to provide comprehensive suggestions, opinions and assistanc

December 29, 2021 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 28, 2021 (December 10, 2021) AMERICA GREAT HEALTH (Exact name of registrant as specified in its charter) Wyoming 000-27873 98-0178621 (State or other jurisdiction of incorpor

December 3, 2021 EX-10.1

Assets Acquisition Agreement, dated November 11, 2021

EX-10.1 2 ex313411.htm EXHIBIT 10.1 Exhibit 10.1 ADVISORY COMMITTEE MEMBER CONSULTING AGREEMENT THIS ADVISORY COMMITTEE MEMBER CONSULTING AGREEMENT (“Agreement”) is made as of November 11, 2021, by and between AMERICA GREAT HEALTH, a California corporation (the “Company”), and Dr. Kevin Buckman (“Consultant”). R E C I T A L S : A. Company has formed an Advisory Committee to provide comprehensive s

December 3, 2021 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 3, 2021 (November 11, 2021) AMERICA GREAT HEALTH (Exact name of registrant as specified in its charter) Wyoming 000-27873 98-0178621 (State or other jurisdiction of incorpora

November 16, 2021 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-CEN ☐ Form N-CSR

NT 10-Q 1 amgreat20211116nt10q.htm FORM NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-CEN ☐ Form N-CSR For the Period Ended: September 30, 2021 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form

September 28, 2021 NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form N-CEN ☐ Form N-CSR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form N-CEN ☐ Form N-CSR For the Period Ended: June 30, 2021 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Period Ended: Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

September 13, 2021 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

8-K 1 amgreat202109138k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 13, 2021 (September 9, 2021) AMERICA GREAT HEALTH (Exact name of registrant as specified in its charter) Wyoming 000-27873 98-0178621 (S

September 13, 2021 EX-10.1

Supplemental Assets Acquisition Agreement, dated September 9, 2021

EX-10.1 2 ex283426.htm EXHIBIT 10.1 Exhibit 10.1 1609 W VALLEY BLVD STE 338 ALHAMBRA CA 91803 USA TEL.1-888-988-1333 FAX.1-626-576-1582 WWW.AAGHUS.COM Supplemental Agreement Party A: AMERICA GREAT HEALTH (CA) Add: 1609 W Valley Blvd. STE 338, Alhambra, CA 91803 Chairman of the Board: Mike Qingkun Wang EIN#: 32-0522173 E-mail: [email protected] Party B: WANG'S PROPERTY INVESTMENT & MANAGEMENT LLC Add

September 8, 2021 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

8-K 1 amgreat202109088k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 8, 2021 (September 3, 2021) AMERICA GREAT HEALTH (Exact name of registrant as specified in its charter) Wyoming 000-27873 98-0178621 (St

September 8, 2021 EX-10.1

Assets Acquisition Agreement, dated September 3, 2021

Exhibit 10.1 1609 W VALLEY BLVD STE 338 ALHAMBRA CA 91803 USA TEL.1-888-988-1333 FAX.1-626-576-1582 WWW.AAGHUS.COM Assets Acquisition Agreement Party A?AMERICA GREAT HEALTH (CA) Add?1609 W Valley Blvd. STE 338, Alhambra CA 91803 Chairman of the Board?President) : Mike Qingkun Wang COO?David Liu Contact?Queena Wang EIN#?32-0522173 [email protected] Party B?WANG?S PROPERTY INVESTMENT & MANAGEME

July 13, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

10-Q 1 amgreat2020123110q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.

July 13, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 America Great Health (Exact name

July 13, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

10-Q 1 amgreat2020093010q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.

July 13, 2021 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2020 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27873 America Great Health (Exact name of regi

June 8, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2019 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 America Great Health (Exact na

June 8, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

10-Q 1 amgreat2020033110q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000

May 20, 2021 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 19, 2021 America Great Health (Exact name of registrant as specified in charter) WYOMING (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Number)

May 20, 2021 EX-2.1

Cooperation Agreement, dated May 18th , 2021 between the Company and Dr. Tsai

EX-2.1 2 ex252037.htm EXHIBIT 2.1 Exhibit 2.1 1609 W VALLEY BLVD STE 338 ALHAMBRA CA 91803 USA TEL.1-626-348-1638 FAX.1-626-576-1582 WWW.AMERICAGREATHEALTH.US Agreement AMERICA GREAT HEALTH (CA) 1609 W Valley Blvd., #338, Alhambra, CA 91803 Mike Qingkun Wang David Liu Queena Wang Aimin Wang, Liping Ren 32-0522173 [email protected] Party A: AMERICA GREAT HEALTH (CA) Registered address: 1609 W Vall

May 7, 2021 10-Q

Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 America Great Health (Exact n

March 23, 2021 10-K

Annual Report - FORM 10-K

10-K 1 amgreat2019063010k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2019 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27873

February 12, 2021 EX-2.1

Cooperation Agreement, dated June 30, 2020 between the Company and Purecell

EX-2.1 2 ex226211.htm EXHIBIT 2.1 Exhibit 2.1 1609 W VALLEY BLVD STE 338ALHAMBRA CA 91803 USA TEL: 1-626-348-1638FAX: 1-626-576-1582 WWW.AMERICAGREATHEALTH.COM COOPERATION AGREEMENT (Document #: AAGH05312020) Party A:AMERICA GREAT HEALTH (CA) Address:1609 W Valley Blvd., #338, Alhambra, CA 91803 CEO (Legal Representative): Mike Qingkun Wang COO:David Liu Board Secretary:Queena Wang Tax Identificat

February 12, 2021 8-K

Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 26, 2021 America Great Health (Exact name of registrant as specified in charter) WYOMING (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Num

January 4, 2021 10-Q

Quarterly Report - FORM 10-Q

10-Q 1 amgreat2019033110q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000

December 21, 2020 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Other Events - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 18, 2020 America Great Health (Exact name of registrant as specified in charter) WYOMING (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Nu

December 10, 2020 10-Q

Quarterly Report - FORM 10-Q

10-Q 1 amgreat2018123110q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.

December 10, 2020 10-Q

Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 America Great Health (Exact n

November 16, 2020 8-K/A

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2020 America Great Health (Exact name of registrant as specified in charter) WYOMING (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File N

November 12, 2020 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2020 America Great Health (Exact name of registrant as specified in charter) WYOMING (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Num

May 11, 2020 EX-16.1

Letter from MJF & Associates, APC to the Securities and Exchange Commission dated May 8, 2020.

Exhibit 16.1 May 8, 2020 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: America Great Health (Commission file number: 000-27873) We have read the statements of America Great Health included under Item 4.01 of Form 8-K to be filed with the SEC on May 8, 2020 and agree with such statements as they pertain to our firm. Sincerely, MJF & Associates, APC 515 S. Flower S

May 11, 2020 8-K/A

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2020 America Great Health (Exact name of registrant as specified in charter) WYOMING (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Number

May 8, 2020 8-K

Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2020 America Great Health (Exact name of registrant as specified in charter) WYOMING (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Number)

March 3, 2020 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 2, 2020 America Great Health (Exact name of registrant as specified in charter) WYOMING (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Number

December 3, 2018 10-K

CWNM / Crown Marketing FORM 10-K (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2018 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27873 America Great Health (Exact name of regi

November 14, 2018 NT 10-Q

CWNM / Crown Marketing FORM NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-SAR ☐ Form N-CSR For the Period Ended: September 30, 2018 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Form 20-F ☐ Transition Report on Form N-SAR ☐ Transition Report on Form 11-K For the Transition Period Ended: Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

October 5, 2018 8-K

Current Report

8-K 1 amgreat201810058k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 5, 2018 America Great Health (Exact name of registrant as specified in charter) WYOMING (State or other jurisdiction of incorporation) 0-2

September 28, 2018 NT 10-K

CWNM / Crown Marketing FORM NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form N-SAR ☐ Form N-CSR For the Period Ended: June 30, 2018 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Form 20-F ☐ Transition Report on Form N-SAR ☐ Transition Report on Form 11-K For the Transition Period Ended: Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

July 2, 2018 8-K

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 26, 2018 America Great Health (Exact name of registrant as specified in charter) WYOMING (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Number

July 2, 2018 EX-16.1

Letter from Sadler, Gibb & Associates, LLC to the Securities and Exchange Commission dated July 2, 2018

Exhibit 16.1 July 2, 2018 Securities and Exchange Commission 100 F Street, N.W. Washington, D.C. 20549 Re: America Great Heath We have read the statements of America Great Health included under Item 4.01 of Form 8-K dated July 2, 2018 and agree with such statements as they pertain to our firm. Sincerely, /s/ Sadler, Gibb & Associates, LLC Sadler, Gibb & Associates, LLC

June 5, 2018 8-K

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2018 America Great Health (Exact name of registrant as specified in charter) WYOMING (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Number)

May 21, 2018 10-Q

CWNM / Crown Marketing 10-Q (Quarterly Report)

10-Q 1 amgreathealth10q033118.htm 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-

May 15, 2018 NT 10-Q

CWNM / Crown Marketing NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-SAR ☐ Form N-CSR For the Period Ended: March 31, 2018 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Form 20-F ☐ Transition Report on Form N-SAR ☐ Transition Report on Form 11-K For the Transition Period Ended: Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

April 25, 2018 8-K

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 18, 2018 America Great Health (Exact name of registrant as specified in charter) WYOMING (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Numbe

April 6, 2018 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 5, 2018 America Great Health (Exact name of registrant as specified in charter) WYOMING (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Number

April 6, 2018 EX-10.2

Rescission Agreement

Exhibit 10.2 RESCISSION AGREEMENT This RESCISSION AGREEMENT (this “Agreement”) is made as of March 30, 2018, by and between Health & Beauty Group, Inc., a California corporation (“Health & Beauty”), and America Great Health (the “Company”) (herein as the “Parties”), and is made with reference to the following undisputed facts: A. The Company and Health & Beauty entered into that certain Agreement

March 5, 2018 8-K

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 5th, 2018 America Great Health (Exact name of registrant as specified in charter) WYOMING (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Numb

February 23, 2018 CORRESP

CWNM / Crown Marketing CORRESP

1609 W VALLEY BLVD STE 338, ALHAMBRA CA 91803, USA. February 23, 2018 Vanessa Robertson Division of Corporation Finance Office of Healthcare & Insurance Securities and Exchange Commission Washington D.C. 20549 Re: America Great Health Form 10-K for the Fiscal Year Ended June 30, 2017 Filed October 13, 2017 File No. 000-27873 Dear Ms. Robertson, This letter is in response to your comment letter dat

February 23, 2018 10-K/A

CWNM / Crown Marketing 10-K/A (Annual Report)

10-K/A 1 amgreathealth10ka063017.htm 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K /A Amendment No. 1 ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2017 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the transition period from to Commission

February 20, 2018 10-Q

CWNM / Crown Marketing 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2017 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 America Great Health (Exact na

February 14, 2018 NT 10-Q

CWNM / Crown Marketing NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form N-SAR ? Form N-CSR For the Period Ended: December 31, 2017 ? Transition Report on Form 10-K ? Transition Report on Form 10-Q ? Transition Report on Form 20-F ? Transition Report on Form N-SAR ? Transition Report on Form 11-K For the Transition Period Ended: Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

February 5, 2018 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 2nd, 2018 America Great Health (Exact name of registrant as specified in charter) WYOMING (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File N

February 5, 2018 EX-16.1

Letter from TAAD LLP dated Feburary 2, 2018 to the Securities and Exchange Commission.

Exhibit 16.1 February 2, 2018 Securities and Exchange Commission 100 F. Street N.W. Washington, DC 20549-7561 Dear Sirs/Madams: We have read 4.01 of America Great Health, formerly Crown Marketing (the ?Company?) Form 8-K to be filed on February 2, 2018 and are in agreement with the statements relating only to TAAD, LLP contained therein. We have no basis to agree or disagree with other matters of

January 17, 2018 EX-10.1

Stock Purchase Agreement dated January 04, 2018

EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 STOCK PURCHASE AGREEMENT This Stock Purchase Agreement (“Agreement”) is made and entered into as of this 4th day of January, 2018, by and between America Great Health, a Wyoming Corporation (the “Purchaser”), and Health & Beauty Group, Inc., a California Corporation (the “Company” or “Seller”). WHEREAS, the Company is engaged in manufacturing and distribut

January 17, 2018 8-K

CWNM / Crown Marketing 8-K (Current Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 04, 2018 America Great Health (Exact name of registrant as specified in charter) WYOMING (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Num

January 9, 2018 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 08, 2018 America Great Health (Exact name of registrant as specified in charter) WYOMING (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Num

November 14, 2017 10-Q

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 America Great Health (Exact n

October 20, 2017 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 18, 2017 America Great Health (Exact name of registrant as specified in charter) WYOMING (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Num

October 13, 2017 10-K

Annual Report - 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2017 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27873 America Great Health (Exact name of regi

September 29, 2017 NT 10-K

Crown Marketing NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form N-SAR ? Form N-CSR For the Period Ended: June 30, 2017 ? Transition Report on Form 10-K ? Transition Report on Form 10-Q ? Transition Report on Form 20-F ? Transition Report on Form N-SAR ? Transition Report on Form 11-K For the Transition Period Ended: Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

June 27, 2017 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

8-K 1 americagreathealth8k062717.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 27, 2017 America Great Health (Exact name of registrant as specified in charter) WYOMING (State or other jurisdiction of incorporation) 0

June 14, 2017 10-Q/A

Quarterly Report - 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A T QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 £ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 America Great Health (Exact nam

May 25, 2017 EX-16.1

May 25, 2017

Exhibit 16.1 May 25, 2017 U.S. Securities and Exchange Commission Office of the Chief Accountant 100F Street Northeast Washington, DC 20549-2000 RE: America Great Health File No. 0-27873 Dear Sir or Madam: We have been furnished with a copy of the response to Item 4.02 of Form 8-K for the event that occurred on May 22, 2017, to be filed by our client, America Great Health. We agree with the statem

May 25, 2017 8-K

Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 25, 2017 America Great Health (Exact name of registrant as specified in charter) WYOMING (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Number)

May 22, 2017 10-Q

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q T QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 £ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 America Great Health (Exact name

May 17, 2017 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

8-K 1 americagreathealth8k051117.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2017 America Great Health (Exact name of registrant as specified in charter) WYOMING (State or other jurisdiction of incorporation) 0-

May 17, 2017 EX-3.1

Articles of Amendment (5)

EX-3.1 2 ex3-1.htm EX-3.1 Exhibit 3.1 Ed Murray Wyoming Secretary of State 2020 Carey Avenue, Suite 700 Cheyenne, WY 82002-0020 Ph. 307.777.7311 Fax 307.777.5339 Email: [email protected] Ed Murray WY Secretary of State FILED: 03/16/2017 04:37PM Original ID: 2010-000586694 Amendment ID: 2017-002033481 Profit Corporation Articles of Amendment 1. Corporation name: Crown Marketing 2. Article number(s)

May 16, 2017 NT 10-Q

Crown Marketing NT 10-Q

asapexpo-nt10k123115.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ? Form 10-K o Form 20-F o Form 11-K ? Form 10-Q o Form N-SAR o Form N-CSR For the Period Ended: March 31, 2017 o Transition Report on Form 10-K o Transition Report on Form 10-Q o Transition Report on Form 20-F o Transition Report on Form N-SAR o Transition Report o

February 21, 2017 10-Q

Crown Marketing CROWN MARKETING 10-Q (Quarterly Report)

Crown Marketing 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

February 15, 2017 NT 10-Q

Crown Marketing 0-Q

Notice of Late Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12B-25 Commission File Number 0-27873 NOTIFICATION OF LATE FILING (Check One): [ ]Form 10-K [ ]Form 11-K [ ] Form 20-F [X] Form 10-Q [ ]Form N-SAR For Period Ended: December 31, 2016 PART I.

January 20, 2017 8-K

Changes in Control of Registrant

Crown Marketing change of control UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

January 4, 2017 10-Q

Crown Marketing CROWN MARKETING 10-Q (Quarterly Report)

Crown Marketing 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

December 16, 2016 10-K

Annual Report - CROWN MARKETING

10-K 1 f10k2016ed2.htm CROWN MARKETING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2016 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-278

December 16, 2016 EX-3

Amended and Restated Articles of Incorporation, as filed June 24, 2016 (4)

EX-3 2 restatedaoi.htm EX 3.4 RESTATED ARTICLES ARTICLES OF RESTATEMENT [filed 6/24/2016 ] OF CROWN MARKETING Pursuant to Section 17-16-1007 of the Wyoming Statutes Annotated, and pursuant to the unanimous written consent of the Board of Directors of Crown Marketing (the “Corporation”), the undersigned director and officer of the Corporation certifies that the following are the Restated Articles o

October 3, 2016 10-Q

Crown Marketing CROWN MARKETING 10-Q (3/31/16) (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [ X ] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 CROWN MARKETING (Exact name

September 30, 2016 NT 10-K

Crown Marketing 0-K

UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12B-25 Commission File Number 0-27873 NOTIFICATION OF LATE FILING (Check One):[X]Form 10-K[ ]Form 11-K[ ] Form 20-F[ ] Form 10-Q[ ]Form N-SAR For Period Ended: June 30, 2016 [ ]Transition Report on Form 10-K [ ]Transition Report on Form 10-Q [ ]Transition Report on Form 20-F [ ]Transition Report on Form N-SAR [ ]Transition Report on Form 11-K For the Transition Period Ended: Read attached instruction sheet before preparing form.

August 11, 2016 10-Q

Crown Marketing CROWN MARKETING (Quarterly Report)

Crown Marketing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [ X ] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2015 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 CROWN MA

June 20, 2016 10-Q

Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q T QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 £ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 CROWN MARKETING (Exact name o

June 2, 2016 8-K

Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 30, 2016 CROWN MARKETING (Exact name of registrant as specified in its charter) WYOMING (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Number)

May 13, 2016 8-K

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

8-K 1 auditorchangemay2016.htm 8K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 5, 2016 CROWN MARKETING (Exact name of registrant as specified in its charter) WYOMING (State or other jurisdiction of incorporation) 0-27873 98-

May 13, 2016 EX-16

May 11, 2016

EX-16 3 f8kletter.htm EXHIBIT 16 May 11, 2016 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-7561 Dear Sirs/Madams: We have read Item 4.01 of Crown Marketing’s Form 8-K dated May 11, 2016, and are in agreement with the statements made therein. Yours truly, /s/ Weinberg & Company, P.A. Los Angeles, California

November 13, 2015 NT 10-Q

Crown Marketing UNITED STATES

UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12B-25 Commission File Number 0-27873 NOTIFICATION OF LATE FILING (Check One):[ ]Form 10-K[ ]Form 11-K[ ] Form 20-F[ X] Form 10-Q[ ]Form N-SAR For Period Ended: September 30, 2015 [ ]Transition Report on Form 10-K [ ]Transition Report on Form 10-Q [ ]Transition Report on Form 20-F [ ]Transition Report on Form N-SAR [ ]Transition Report on Form 11-K For the Transition Period Ended: Read attached instruction sheet before preparing form.

October 13, 2015 10-K

Annual Report - CROWN MARKETING 10-K

Crown Marketing 10-K 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

October 13, 2015 EX-3

ARTICLES OF AMENDMENT CERTIFICATE OF DESIGNATION As filed with the Wyoming Secretary of State on September 4, 2015

EX-3 2 codserisa.htm CERTIFICATE OF DESIGNATION ARTICLES OF AMENDMENT FOR CERTIFICATE OF DESIGNATION As filed with the Wyoming Secretary of State on September 4, 2015 Jay Hooper certifies he is the President of Crown Marketing, a Wyoming corporation (hereinafter referred to as the "Corporation" or the "Company"); that, pursuant to the Corporation's Articles of Incorporation, as amended, and Sectio

September 28, 2015 NT 10-K

Crown Marketing 0-K

UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12B-25 Commission File Number 0-27873 NOTIFICATION OF LATE FILING (Check One):[X]Form 10-K[ ]Form 11-K[ ] Form 20-F[ ] Form 10-Q[ ]Form N-SAR For Period Ended: June 30, 2015 [ ]Transition Report on Form 10-K [ ]Transition Report on Form 10-Q [ ]Transition Report on Form 20-F [ ]Transition Report on Form N-SAR [ ]Transition Report on Form 11-K For the Transition Period Ended: Read attached instruction sheet before preparing form.

August 13, 2015 S-8

Crown Marketing

Crown Marketing Form S-8 As filed with the Securities and Exchange Commission on August 13, 2015 Registration No.

August 13, 2015 EX-4

CONSULTING AGREEMENT

Consulting Agreement CONSULTING AGREEMENT This Consulting Agreement (the ?Agreement?) is effective as of August 3rd, 2015, (the ?Effective Date?) by and between Crown Marketing .

August 13, 2015 EX-4

RESOLUTIONS ADOPTED BY UNANIMOUS WRITTEN CONSENT

Social Media Plan RESOLUTIONS ADOPTED BY UNANIMOUS WRITTEN CONSENT OF THE BOARD OF DIRECTORS OF CROWN MARKETING A Wyoming Corporation The undersigned, constituting the sole Director of the Corporation acting pursuant to the authority of ?17-16-821 of the Wyoming Business Corporation Act, hereby consents to take the following actions and adopts the following recitals and resolutions effective as of August 3, 2015.

May 15, 2015 10-Q/A

Quarterly Report - CROWN EX 32

Crown ex 32 EXHIBIT 32 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report of Crown Marketing (the "Company") on Form 10-Q for the period ending March 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Jay Hooper, President and Financial Offic

May 15, 2015 10-Q

Quarterly Report - CROWN MARKETING 10-Q

10-Q 1 crownmarketings315q.htm CROWN MARKETING 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission

February 23, 2015 10-Q/A

Quarterly Report - CROWN MARKETING

Crown Marketing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A T QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2014 £ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 CROWN MARKET

February 23, 2015 10-Q/A

Quarterly Report - CROWN MARKETING

Crown Marketing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A [ X ] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 CROWN

February 13, 2015 10-Q

Quarterly Report - CROWN MARKETING

Crown Marketing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q T QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2014 £ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 CROWN MARKETIN

November 14, 2014 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [ X ] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 [ ] TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [ X ] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27873 CROWN MARKETING (Exact

September 19, 2014 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM 10-K

Crown Marketing Annual Report for 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

September 18, 2014 10-K

Annual Report - CROWN MARKETING ANNUAL REPORT FOR 2014

Crown Marketing Annual Report for 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

May 13, 2014 10-Q

Quarterly Report - CROWN MARKETING 10Q

10-Q 1 crown10q051114.htm CROWN MARKETING 10Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0

May 13, 2014 EX-3

PROFIT CORPORATION ARTICLES OF AMENDMENT

PROFIT CORPORATION ARTICLES OF AMENDMENT 1. Corporation Name Crown Marketing 2. Article(s) FIRST is amended as follows: The name of the Corporation shall be Crown Marketing 3. If the amendment provides for an exchange, reclassification, or cancellation of issued shares, provisions for implementing the amendment if not contained in the amendment itself which may be made upon facts objectively ascer

February 14, 2014 10-Q

Crown Marketing OKRA, INC. (Quarterly Report)

10-Q 1 cwnm10q021014final.htm OKRA, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2013 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000

February 14, 2014 EX-3

PROFIT CORPORATION ARTICLES OF AMENDMENT

PROFIT CORPORATION PROFIT CORPORATION ARTICLES OF AMENDMENT 1. Corporation Name Crown Marketing 2. Article(s) FIRST is amended as follows: The name of the Corporation shall be Okra, Inc. 3. If the amendment provides for an exchange, reclassification, or cancellation of issued shares, provisions for implementing the amendment if not contained in the amendment itself which may be made upon facts obj

February 5, 2014 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report(Date of Earliest Event Reported): January 31, 2014 CROWN MARKETING (Exact name of registrant as specified in its charter) WYOMING (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Numbe

January 27, 2014 PRER14C

- REVISED 14C

Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No.

December 23, 2013 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Crown Marketing 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

December 5, 2013 8-K

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Other Events - 8K

UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report(Date of Earliest Event Reported): December 2, 2013 CROWN MARKETING (Exact name of registrant as specified in its charter) WYOMING (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commiss

December 5, 2013 SC 14F1

- 14F

Schedule 14F-1 Information Statement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14F-1 INFORMATION STATEMENT PURSUANT TO SECTION 14(F) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 14f-1 THEREUNDER CROWN MARKETING (Exact Name of Registrant as Specified in Its Charter) Wyoming (State or Other Jurisdiction of Incorporation) 000-27873 98-0178621 (Commission File Number) (IRS Employer Identification No.

December 5, 2013 PRE 14C

- PRE14C

PRE 14C 1 f14c.htm PRE14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant [x] Filed by the Party other than the Registrant [ ] Check the appropriate box: [X] Preliminary Information Statement [ ] Definitive Information Statement [ ] Confidential, for use of the Commission only (as permitted by Rule 14c-5(d)(2) CROWN MA

December 5, 2013 EX-10

Lease Agreement between Okra Energy, Inc. and Temple CB, LLC (4)

SAMPLE COMMERCIAL LEASE AGREEMENT COMMERCIAL LEASE AGREEMENT THIS LEASE AGREEMENT is made and entered into on December 1, 2013, by and between Temple CB, LLC, whose address is 4350 Temple City Boulevard, El Monte, California 91731 (hereinafter referred to as "Landlord"), and Okra Energy, Inc.

December 5, 2013 EX-2

Agreement and Plan of Reorganization between the Company and Okra Energy, Inc. dated December 2, 2013 (1).

Converted by EDGARwiz AGREEMENT AND PLAN OF REORGANIZATION THIS AGREEMENT AND PLAN OF REORGANIZATION (the "Agreement") is dated December 2, 2013, and is by and between Crown Marketing, a Wyoming corporation (the "Company") and Okra Energy, Inc.

November 18, 2013 10-Q

Quarterly Report - CROWN MARKETING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 oTRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-27873 CROWN MARKETING (Exact name of registrant as specified in its charter) Wyoming 98-0178621 (State or other jurisdiction of incorporation or organization) (I.

November 15, 2013 NT 10-Q

-

notice of late filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12B-25 Commission File Number 0-27873 NOTIFICATION OF LATE FILING (Check One):[ ]Form 10-K[ ]Form 11-K[ ] Form 20-F[X ] Form 10-Q[ ]Form N-SAR For Period Ended: September 30, 2013 [ ]Transition Report on Form 10-K [ ]Transition Report on Form 10-Q [ ]Transition Report on Form 20-F [ ]Transition Report on Form N-SAR [ ]Transition Report on Form 11-K For the Transition Period Ended: Read attached instruction sheet before preparing form.

October 2, 2013 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

Crown Marketing UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K [x] Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended June 30, 2013 [ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 0-27873 CROWN MARKETING

October 1, 2013 NT 10-K

- NOTICE

notice of late filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12B-25 Commission File Number 0-27873 NOTIFICATION OF LATE FILING (Check One):[X]Form 10-K[ ]Form 11-K[ ] Form 20-F[ ] Form 10-Q[ ]Form N-SAR For Period Ended: June 30, 2013 [ ]Transition Report on Form 10-K [ ]Transition Report on Form 10-Q [ ]Transition Report on Form 20-F [ ]Transition Report on Form N-SAR [ ]Transition Report on Form 11-K For the Transition Period Ended: Read attached instruction sheet before preparing form.

May 14, 2013 10-Q

Quarterly Report - CROWN MARKETING

CROWN MARKETING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 oTRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-27873 CROWN MARKETING (Exact name of registrant as specified in its charter) Wyoming 98-0178621 (State or other jurisdiction of incorporation or organization) (I.

February 1, 2013 10-Q

Quarterly Report - CROWN MARKETING 10Q FOR THE QUARTER ENDED DECEMBER 31, 2012

Crown Marketing 10Q for the Quarter ended December 31, 2012 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2012 oTRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-27873 CROWN MARKETING (Exact name of registrant as specified in its charter) Wyoming 98-0178621 (State or other jurisdiction of incorporation or organization) (I.

November 19, 2012 10-Q

Quarterly Report - CROWN MARKETING

10-Q 1 crownseptq2012111912.htm CROWN MARKETING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2012 oTRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Comm

November 14, 2012 NT 10-Q

- NOTICE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12B-25 Commission File Number 0-27873 NOTIFICATION OF LATE FILING (Check One):[ ]Form 10-K[ ]Form 11-K[ ] Form 20-F[ X ] Form 10-Q[ ]Form N-SAR For Period Ended: September 30, 2012 [ ]Transition Report on Form 10-K [ ]Transition Report on Form 10-Q [ ]Transition Report on Form 20-F [ ]Transition Report on Form N-SAR [ ]Transition Report on Form 11-K For the Transition Period Ended: Read attached instruction sheet before preparing form.

October 3, 2012 8-K/A

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Completion of Acquisition or Disposition of Assets, Other Events - REVISED 8-K TO PROVIDE PAY DATE

UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report(Date of Earliest Event Reported): September 27, 2012 CROWN MARKETING (Exact name of registrant as specified in its charter) WYOMING (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Com

October 2, 2012 EX-100.CAL

-

October 2, 2012 EX-100.LAB

-

Related Party Transactions Disclosure [Text Block] Accounting Policies Common stock Accounts payable Notes payable Current assets Cash flows from operating activities: Net loss Entity Public Float Related Party Disclosures Cash and Cash Equivalents Disclosure [Text Block] (Increase)decrease in prepaid expenses Document Type Shareholders' equity Basic and diluted-actual per share Supplementary cash

October 2, 2012 EX-100.INS

-

10-K 2012-06-30 false CROWN MARKETING 0001098009 -06-30 190067600 27150500 Smaller Reporting Company No No No 2012 FY -1975 -1975 400 -1975 400 7200 7200 -22024 -22024 21100 -23999 -2899 60 60 -56261 -56261 21160 -80260 -59100 -56261 -22024 -80260 5475 -7050 -622 5815 5193 91 91 40972 3809 44781 -15820 -13975 -30195 -250 -250 -250 -250 60 7600 7660 9666 9666 9726 20700 30826 -6344 6725 381 6725 381 4500 4500 456 456 4044 4044 43467600 42293390 0.

October 2, 2012 EX-100.PRE

-

October 2, 2012 EX-10

Promissory Note to Strategic Global Resources, Ltd. (3)

PROMISSORY NOTE Dated March 31, 2012 FOR VALUE RECEIVED, the undersigned Crown Marketing, a Wyoming corporation ("Maker") promises to pay to the order of Strategic Global Resources, Ltd.

October 2, 2012 10-K

Annual Report - 10K

Crown Marketing Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

October 2, 2012 EX-100.DEF

-

October 2, 2012 EX-10

Promissory Note to Farrington Pharmaceuticals, LLC (3)

PROMISSORY NOTE Dated September 27, 2012 FOR VALUE RECEIVED, the undersigned Crown Marketing, a Wyoming corporation ("Maker") promises to pay to the order of Farrington Pharmaceuticals, LLC ("Lender"), at its principal office, or at such other place as may be designated in writing by the holders of this Promissory Note ("Note"), the principal sum of ONE HUNDRED FORTY THOUSAND AND 00/100 DOLLARS ($140,000.

October 2, 2012 EX-100.SCH

-

200000 - Disclosure - Organization, Consolidation and Presentation of Financial Statements link:presentationLink link:definitionLink link:calculationLink 148600 - Statement - Statement of Shareholders' Equity and Other Comprehensive Income link:presentationLink link:definitionLink link:calculationLink 000020 - Statement - CROWN MARKETING AND SUBSIDIARY STATEMENTS OF STOCKHOLDERS' EQUITY link:prese

September 27, 2012 8-K

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Completion of Acquisition or Disposition of Assets, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report(Date of Earliest Event Reported): September 27, 2012 CROWN MARKETING (Exact name of registrant as specified in its charter) WYOMING (State or other jurisdiction of incorporation) 0-27873 98-0178621 (Commission File Num

June 5, 2012 10-Q/A

Quarterly Report - CROWN MARKETING MARCH 31, 2012 10-Q

Crown Marketing March 31, 2012 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q/A x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2012 oTRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-27873 CROWN MARKETING (Exact name of registrant as specified in its charter) Wyoming 98-0178621 (State or other jurisdiction of incorporation or organization) (I.

May 15, 2012 10-Q

Quarterly Report - CROWN MARKETING MARCH 31, 2012 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2012 oTRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-27873 CROWN MARKETING (Exact name of registrant as specified in its charter) Wyoming 98-0178621 (State or other jurisdiction of incorporation or organization) (I.

May 15, 2012 NT 10-Q

- LATE NOTICE

UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12B-25 Commission File Number 0-27873 NOTIFICATION OF LATE FILING (Check One):[ ]Form 10-K[ ]Form 11-K[ ] Form 20-F[ X ] Form 10-Q[ ]Form N-SAR For Period Ended: March 31, 2012 [ ]Transition Report on Form 10-K [ ]Transition Report on Form 10-Q [ ]Transition Report on Form 20-F [ ]Transition Report on Form N-SAR [ ]Transition Report on Form 11-K For the Transition Period Ended: Read attached instruction sheet before preparing form.

March 19, 2012 8-A12G

-

Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

February 1, 2012 CORRESP

-

August 8, 2008 CROWN MARKETING 25 Mountaire Court, Highland Avenue London, UK NW9 0QA +447896150866 February 1, 2012 Michael R.

January 20, 2012 CORRESP

-

November 21, 2011 Carlos E. Duque Attorney at Law 103 Concord Ave. Suite 2-2 Somerville, MA 02143 (317) 270-3353 January 20, 2012 Michael R. Clampitt Senior Attorney Securities & Exchange Commission 450 Fifth Street, NW Washington, DC 20549 Re: Crown Marketing Amendment No. 2 to Registration Statement on Form S-1 Filed November 9, 2011 File No. 333-176776 Dear Mr. Clampitt: The Company responds to

January 20, 2012 S-1/A

-

As filed with the Securities and Exchange Commission on January 20, 2012 As filed with the Securities and Exchange Commission on January 20, 2012 Registration No.

November 9, 2011 S-1/A

-

As filed with the Securities and Exchange Commission on November 9, 2011 Registration No.

November 9, 2011 CORRESP

-

October 10, 2011 Carlos E. Duque Attorney at Law 103 Concord Ave. Suite 2-2 Somerville, MA 02143 (317) 270 3353 November 9, 2011 Michael R. Clampitt, Senior Attorney Securities & Exchange Commission 450 Fifth Street, NW Washington, DC 20549 Re: Crown Marketing Registration Statement on Form S-1 Filed October 14, 2011 File No. 333-176776 Dear Mr. Clampitt: The Company responds to the staff’s commen

October 14, 2011 EX-4

LOCKUP AGREEMENT

LOCKUP AGREEMENT LOCKUP AGREEMENT dated September 1, 2011 The undersigned shareholder of Crown Marketing agrees not to sell any of its shares of common stock in any amount greater than two thousand (2,000) shares per calendar month until June 30, 2013.

October 14, 2011 CORRESP

-

October 10, 2011 Carlos E. Duque Attorney at Law 103 Concord Ave. Suite 2-2 Somerville, MA 02143 (317) 270 3353 October 14, 2011 Michael R. Clampitt, Senior Attorney Securities & Exchange Commission 450 Fifth Street, NW Washington, DC 20549 Re: Crown Marketing Registration Statement on Form S-1 Filed September 9, 2011 File No. 333-176776 Dear Mr. Clampitt: The Company responds to the staff’s comme

October 14, 2011 EX-2

AGREEMENT AND PLAN OF REORGANIZATION

Converted by EDGARwiz AGREEMENT AND PLAN OF REORGANIZATION THIS AGREEMENT AND PLAN OF REORGANIZATION (the “Agreement”) is dated July 2, 2010, and is by and between Crown Marketing, a Wyoming corporation (the “Company”) and Green4Green, a Wyoming corporation (“Green4Green”).

October 14, 2011 S-1/A

-

As filed with the Securities and Exchange Commission on October 14, 2011 Registration No.

October 14, 2011 EX-4

FORM OF CLASS A COMMON STOCK PURCHASE WARRANT

THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.

October 14, 2011 EX-3

Articles of Merger (2)

ARTICLES OF MERGER THESE ARTICLES OF MERGER, dated as of July 9, 2010, are entered into by and between Crown Marketing, a Wyoming corporation ("Crown") and SPCL Holding Corporation, a Delaware corporation ("Holding"), to effectuate the merger of Holding with and into Crown (the "Merger").

September 9, 2011 S-1

Registration Statement -

As filed with the Securities and Exchange Commission on September 9, 2011 Registration No.

September 9, 2011 EX-3

Bylaws (2)

BYLAWS FOR THE REGULATION, EXCEPT AS OTHERWISE PROVIDED BY STATUTE OR ITS ARTICLES OF INCORPORATION, OF CROWN MARKETING a Wyoming corporation ARTICLE I OFFICES Section 1.

September 9, 2011 EX-3

Articles of Incorporation (1)*

ARTICLES OF INCORPORATION OF CROWN MARKETING The undersigned, desiring to form a corporation for profit under the Wyoming Business Corporation Act, does hereby certify as follows: FIRST: The name of the corporation shall be Crown Marketing.

September 9, 2011 EX-2

FORM OF CLASS A COMMON STOCK PURCHASE WARRANT

NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.

May 15, 2001 EX-27

EX-27

5 this schedule contains summary financial information extracted from the statements for the 3 months ended march 31, 2001 and as of such date and is qualified in its entirety by reference to such financial statements. 3-MOS Jan-01-2001 Dec-31-2001 Mar-31-2001 108,714 0 0 0 0 108,714 0 0 108,714 0 0 0 0 61 108,733 108,714 0 1,557 0 5,139 0 0 0 (3,582) 0 (3,582) 0 0 0 (3,582) (0) (0)

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista